NA
MRK icon

Nordwand Advisors’s Merck MRK Stock Holding History

Nordwand Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.5M Buy
45,728
+110
+0.2% +$12.7K 0.96% 39
2025
Q4 		$4.8M Sell
45,618
-461
-1% -$43.3K 0.84% 44
2025
Q3 		$3.87M Buy
46,079
+1,207
+3% +$99.4K 0.61% 51
2025
Q2 		$3.55M Buy
44,872
+43,951
+4,772% +$3.49M 0.56% 50
2025
Q1 		$82.7K Hold
921
– – 0.03% 38
2024
Q4 		$91.6K Hold
921
– – 0.04% 38
2024
Q3 		$105K Sell
921
-2,567
-74% -$305K 0.03% 36
2024
Q2 		$432K Sell
3,488
-5,883
-63% -$758K 0.19% 17
2024
Q1 		$1.24M Sell
9,371
-15,488
-62% -$1.91M 0.48% 21
2023
Q4 		$2.71M Hold
24,859
– – 0.72% 21
2023
Q3 		$2.56M Sell
24,859
-3,861
-13% -$416K 0.51% 18
2023
Q2 		$3.31M Buy
28,720
+27,799
+3,018% +$3.16M 0.57% 16
2023
Q1 		$98K Buy
+921
New +$99.4K 0.02% 51

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nordwand Advisors's MRK Position: Q1 2026 in Review

Nordwand Advisors increased its Merck (MRK) stake by 0.24% in Q1 2026, buying an estimated $12.7K and bringing the position to 45,728 shares worth $5.5M. The position accounts for 0.96% of the portfolio, ranked #39.

Nordwand Advisors first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Nordwand Advisors held 45,728 shares of Merck worth $5.5M as of Q1 2026.
  • Nordwand Advisors bought 110 Merck shares in Q1 2026, an estimated $12.7K.
  • Merck made up 0.96% of Nordwand Advisors's portfolio in Q1 2026, its #39 holding.
  • Nordwand Advisors first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Nordwand Advisors's 13F filing for Q1 2026, filed 7 May 2026.